Status:
UNKNOWN
Long Term Outcomes After EUS-guided Ablation for Cystic Tumors of the Pancreas
Lead Sponsor:
Asan Medical Center
Conditions:
Cystic Tumors of the Pancreas
Eligibility:
All Genders
20-85 years
Phase:
PHASE2
PHASE3
Brief Summary
Cystic lesions of the pancreas are defined as round, fluid-filled structures within the pancreas detected by radiologic imaging. With widespread use of cross-sectional imaging modalities for various i...
Eligibility Criteria
Inclusion
- uni- or oligo-locular cystic tumors
- indeterminate cystic tumors for which EUS-guided fine needle aspiration (FNA) was required to obtain additional information
- cystic tumors that increased in size during the observation period
Exclusion
- cystic tumors which had the typical morphology of serous cystadenomas (i.e., honeycomb appearance) and pseudocysts (i.e., parenchymal changes)
- evidence of communication between the cystic lesion and the main pancreatic duct according to endoscopic retrograde pancreatograms
- overt carcinomas with peripancreatic invasion
- patients with a bleeding tendency (prothrombin time \> 1.5 international normalized ratio \[INR\] or platelet count \< 50,000/μL).
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2016
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00689715
Start Date
June 1 2006
End Date
August 1 2016
Last Update
July 26 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asan Medical Center, University of Ulsan College of Medicine
Seoul, South Korea, 138-736